Neurizon Therapeutics Limited enterprise value

The Enterprise Value as of October 2026 (TTM) for Neurizon Therapeutics Limited (NUZ.AX) is 53.16M

According to Neurizon Therapeutics Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 53.16M. This represents a change of -3.96% compared to the average of 55.35M of the last 4 quarters.

Neurizon Therapeutics Limited (NUZ.AX) Historical Enterprise Value (quarterly & annually)

How has NUZ.AX Enterprise Value performed in the past?

The mean historical Enterprise Value of Neurizon Therapeutics Limited over the last ten years is 28.87M. The current 53.16M Enterprise Value has changed 84.16% with respect to the historical average. Over the past ten years (40 quarters), NUZ.AX's Enterprise Value was at its highest in in the June 2024 quarter at 77.07M. The Enterprise Value was at its lowest in in the December 2006 quarter at 0.

Neurizon Therapeutics Limited (NUZ.AX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Neurizon Therapeutics Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Neurizon Therapeutics Limited (NUZ.AX) Average Enterprise Value

How has NUZ.AX Enterprise Value performed in the past?

The current Enterprise Value of Neurizon Therapeutics Limited (NUZ.AX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Neurizon Therapeutics Limited (NUZ.AX) Enterprise Value vs. Peers

How is NUZ.AX’s Enterprise Value compared to its peers?

Neurizon Therapeutics Limited’s Enterprise Value is less than Live Verdure Ltd (70.33M), greater than Kazia Therapeutics Limited (-50667788.32), greater than Bionomics Limited (-999744.00), greater than Medlab Clinical Limited (14.96M), greater than Hexima Limited (-992936.00), greater than Regeneus Ltd (5.32M), greater than Antisense Therapeutics Limited (1.93M), greater than Exopharm Limited (1.82M), greater than Respiri Limited (52.51M), greater than Living Cell Technologies Limited (21.43M),

Build a custom stock screener for Neurizon Therapeutics Limited (NUZ.AX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Neurizon Therapeutics Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Neurizon Therapeutics Limited (NUZ.AX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Neurizon Therapeutics Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.